Image_6_Upregulated IL-6 Indicates a Poor COVID-19 Prognosis: A Call for Tocilizumab and Convalescent Plasma Treatment.TIF by Jian Wu (41301)

“…Two specific treatments, namely, tocilizumab and convalescent plasma therapy (CPT), decreased the level of IL-6 and relieved inflammation. …”

Image_1_Upregulated IL-6 Indicates a Poor COVID-19 Prognosis: A Call for Tocilizumab and Convalescent Plasma Treatment.TIF by Jian Wu (41301)

“…Two specific treatments, namely, tocilizumab and convalescent plasma therapy (CPT), decreased the level of IL-6 and relieved inflammation. …”

Image_3_Upregulated IL-6 Indicates a Poor COVID-19 Prognosis: A Call for Tocilizumab and Convalescent Plasma Treatment.TIF by Jian Wu (41301)

“…Two specific treatments, namely, tocilizumab and convalescent plasma therapy (CPT), decreased the level of IL-6 and relieved inflammation. …”

Image_4_Upregulated IL-6 Indicates a Poor COVID-19 Prognosis: A Call for Tocilizumab and Convalescent Plasma Treatment.TIFF by Jian Wu (41301)

“…Two specific treatments, namely, tocilizumab and convalescent plasma therapy (CPT), decreased the level of IL-6 and relieved inflammation. …”

Active-Site Models for the Nickel–Iron Hydrogenases: Effects of Ligands on Reactivity and Catalytic Properties by Maria E. Carroll (1821628)

“…Acid–base measurements indicate that changing from Ni(dppe) (dppe = Ph₂PCH₂CH₂PPh₂) to Ni(dcpe) decreases the acidity of the cationic hydride complexes by 2.5 p<i>K</i>_a^PhCN units, from ∼11 to ∼13.5 (previous work showed that substitution at Fe leads to more dramatic effects). …”

Incidence and prediction of intraoperative and postoperative cardiac arrest requiring cardiopulmonary resuscitation and 30-day mortality in non-cardiac surgical patients by Heiko A. Kaiser (8333448)

“…We proposed a simplified approach compromised of five-factor model to identify patients at high risk. …”

Data_Sheet_1_A Novel Third Wave Contextual Approach of Positive Behavior Support in School for Adolescent at High Psychosocial Risk: Rationale, Feasibility, and First Pilot Outcome... by Flavia Marino (8060402)

“…Third wave cognitive-behavioral interventions are increasingly becoming the chosen instruments to support psychological intervention for young people and adolescents. In this study, we aim to test the feasibility and the adequacy of the outcome measures of an intervention for adolescents at high psychosocial risk, using a modified Discoverer, Noticer, Advisor and Values (DNA-V) protocol aimed at increasing flexible and positive values. …”

Soluble polyP restores survival in NHS and blocks complement deposition on serum sensitive F62 strain. by Benedetta Manca (15810991)

Table_3_Longitudinal Cytokine Profile in Patients With Mild to Critical COVID-19.xlsx by Lowell Ling (8433594)

“…Furthermore, 11 cytokines were consistently different in both early and late phases, including seven (growth-regulated oncogene-alpha (GRO-α), IL-1RA, IL-6, IL-8, IL-10, IP-10, and MIG) that increased and four (FGF-2, IL-5, macrophage-derived chemokine (MDC), and MIP-1α) that decreased from mild to severe/critical patients. …”

Table_2_Longitudinal Cytokine Profile in Patients With Mild to Critical COVID-19.xlsx by Lowell Ling (8433594)

“…Furthermore, 11 cytokines were consistently different in both early and late phases, including seven (growth-regulated oncogene-alpha (GRO-α), IL-1RA, IL-6, IL-8, IL-10, IP-10, and MIG) that increased and four (FGF-2, IL-5, macrophage-derived chemokine (MDC), and MIP-1α) that decreased from mild to severe/critical patients. …”

Table_1_Longitudinal Cytokine Profile in Patients With Mild to Critical COVID-19.xlsx by Lowell Ling (8433594)

“…Furthermore, 11 cytokines were consistently different in both early and late phases, including seven (growth-regulated oncogene-alpha (GRO-α), IL-1RA, IL-6, IL-8, IL-10, IP-10, and MIG) that increased and four (FGF-2, IL-5, macrophage-derived chemokine (MDC), and MIP-1α) that decreased from mild to severe/critical patients. …”

Image_1_Longitudinal Cytokine Profile in Patients With Mild to Critical COVID-19.tif by Lowell Ling (8433594)

“…Furthermore, 11 cytokines were consistently different in both early and late phases, including seven (growth-regulated oncogene-alpha (GRO-α), IL-1RA, IL-6, IL-8, IL-10, IP-10, and MIG) that increased and four (FGF-2, IL-5, macrophage-derived chemokine (MDC), and MIP-1α) that decreased from mild to severe/critical patients. …”

Image_2_Longitudinal Cytokine Profile in Patients With Mild to Critical COVID-19.tif by Lowell Ling (8433594)

“…Furthermore, 11 cytokines were consistently different in both early and late phases, including seven (growth-regulated oncogene-alpha (GRO-α), IL-1RA, IL-6, IL-8, IL-10, IP-10, and MIG) that increased and four (FGF-2, IL-5, macrophage-derived chemokine (MDC), and MIP-1α) that decreased from mild to severe/critical patients. …”

Improving a Natural CaMKII Inhibitor by Random and Rational Design by Steven J. Coultrap (203683)

“…Indeed, the potency of the optimized peptide CN19o was >250fold improved (IC50 <0.4 nM), and CN19o has characteristics of a tight-binding inhibitor. …”

DataSheet_1_Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis.docx by Eva Schrezenmeier (6261917)

“…Thus, immunogenicity of novel SARS-CoV-2 vaccines might be impaired in this group. To determine immunogenicity of SARS-CoV-2 vaccination in patients with chronic dialysis, we analyzed the humoral and T-cell response after two doses of mRNA vaccine Tozinameran (BNT162b2 BioNTech/Pfizer). …”

DataSheet_1_Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis.docx by Eva Schrezenmeier (6261917)

“…Thus, immunogenicity of novel SARS-CoV-2 vaccines might be impaired in this group. To determine immunogenicity of SARS-CoV-2 vaccination in patients with chronic dialysis, we analyzed the humoral and T-cell response after two doses of mRNA vaccine Tozinameran (BNT162b2 BioNTech/Pfizer). …”

Contribution of polyP in restoring serum resistance of sialylated F62 depends on NHS tested. by Benedetta Manca (15810991)

<i>Δhyr1</i> exhibits a virulence defect. by Kun Huang (136241)

“…<p>Δ<i>hyr1</i> mutants display a decrease in pathogenicity compared to wild type, on susceptible barley and rice. …”

Seroprevalence and different demographics across EU countries determine the vaccine uptake required for population immunity. by Simon Bauer (11378195)

Principle component analysis (PCA) plots of anti-CsAWA specific antibodies and cytokines from <i>Cs</i>- and <i>Cs</i>+ individuals. by Shuo Kan (13766867)